A few weeks ago we were buzzing about a posting in which several Yahoo! insiders and outsiders were ranked with the probability they might succeed embattled CEO Terry Semel. The scuttlebutt amongst media insiders: Yahoo! is disorganized, without a unifying personality to lead the company, weak on strategy and thinly-staffed. First among the contenders to take over Terry's job and charge forth with a new mission was CFO Susan Decker.
It seems as if the "bookies" were right. Tonight Yahoo! Inc. (NASDAQ:YHOO) got a reorganization. In the press release, the company announces it has divided itself into three sections: the Audience Group, the Advertiser & Publisher Group, and the Technology Group. What's more, COO Dan Rosensweig is leaving the company in March (he was rumored to be a rival to Decker for the CEO spot). Decker will head the Advertiser & Publisher Group (i.e. where the money is), certainly a nod toward her potential to take over the "corner cube" from Semel.
Buzz started at 4 p.m. local time: there was an internal company-wide executive level webcast. Nothing says "someone is getting fired" like "internal company-wide executive-level webcast." At least not in a web company! The response so far: "no surprise," "no surprise" that Project Panama is being set as a priority for the new Technology group (and, from the same post, "If you can't sum up a unit in 30 words maybe it's not streamlined enough"), "where is Jeff Weiner, Yahoo!'s former golden boy?" and, from an insider, why not Britney Spears as CEO? [Or, at the very least, the head of the audience group, for which a search party has been launched.]
Last updated: February 13, 2012: 07:29 AM
Hot Stocks
DailyFinance Headlines
- Suddenly, Amazon Doesn't Love Its Moms Anymore
- How State Taxes Put a Bigger Pinch on the Poor
- 4 Money-Etiquette Questions Answered
- Walmart's New Health Food Push: Is It Too Hard to Swallow?
- Newlyweds, Don't Let the IRS Spoil Your Honeymoon
Benzinga Headlines
- Michigan Consumer Sentiment Index Drops
- Don't Bank on Barclays
- GSV Capital Punished for Expanding Facebook Investment
- Chesapeake Gently Lets Go of Gas
- How to Profit off Addicts
TheFlyOnTheWall.com Headlines
- Symantec management to meet with UBS
- Boeing: Dreamliner glitch won't slow production, CNBC reports
- NetApp downgraded to Hold from Buy at ThinkEquity
- Pricing for ultrabooks won't hit 'sweet spot' until 2013, DigiTimes says
- EQT Corporation subsidiary files registration statement
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
WalletPop Headlines
- Suddenly, Amazon Doesn't Love Its Moms Anymore
- How State Taxes Put a Bigger Pinch on the Poor
- 4 Money-Etiquette Questions Answered
- Walmart's New Health Food Push: Is It Too Hard to Swallow?
- Newlyweds, Don't Let the IRS Spoil Your Honeymoon
My Portfolios
Track your stocks here!
Find out why more people track their portfolios on AOL Money & Finance then anywhere else.
BloggingStocks Partners
More from AOL Money & Finance
- Business News
- Stock Screener
- Stock Quotes
- Stock Charts
- Banking
- Identity Theft
- DJIA
- Debt Management
- Loans
- Auto Loan
- Mortgages
- Taxes
- Retirement
- Insurance
- Small Business
- Earnings
- Tech News
- Tax Forms
- Tax Deductions
- Tax Credit
- Tax Audit
- Tax Advice
- Stock Ticker
- Stock Brokers
- Resume Builder
- Pig Flu
- Online Tax Filing
- Madoff
- Investing For Retirement
- Income Tax
- Historical Stock Prices
- GOOG
- ETF Investing
- Deals
- DailyFinance
- Crude Oil Prices
- Credit Score Calculator
- Common Tax Filing Mistakes
- AMT
BioHealth Investor Headlines
- Can Human Genome Really Double Its Stock Price? (HGSI)
- Alimera Implosion Analysis, What Is Next (ALIM, PSDV)
- Implosion Analysis For Targacept… What Lies Ahead? (TRGT, AZN)
- Rare Analyst Calls With Huge Upside in Vical and VIVUS (VICL, VVUS, BMY)
- Top Biotechs With Upside Ahead of Earnings (GILD, AMLN, ARIA, INCY, JAZZ, DNDN, HGSI, ILMN, AMGN, CELG, BIIB, BMRN, LIFE, REGN, AMLN, CBST, ONXX, THRX, VPHM)
Walmart's New Health Food Push: Is It Too Hard to Swallow?
Bonds Are a 'Safe' Investment: A Big Lie Gets Even Bigger

